Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Theravance Initiates Study in ALI caused by COVID-19

contractpharmaApril 24, 2020

Tag: COVID-19 , TD-0903 , Theravance Biopharma, Inc. , ALI

PharmaSources Customer Service